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The authors regret that the text describing the ﬁltering of the RNA-
Seq data contains an inaccuracy. We would like to correct this in-
formation in two places within the manuscript.
In the Materials and Methods section 2.5, 6th sentence, it should
read: “Here, 4115 diﬀerentially expressed transcripts mapping to 4036
unique Smp gene identiﬁers were classiﬁed.”
In the Materials and methods section 2.6, 10th sentence, it should
read: “To illustrate an overview of the genome locations and diﬀerential
expression levels of the 4057 Smps (4115 transcripts) in the ﬁltered
RNA-Seq dataset, a Circos plot (Krzywinski et al., 2009) was generated
using the S. mansoni genome v 5.2.”
The authors would like to apologise for any inconvenience caused.
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